TALLAC THERAPEUTICS Trademark

Trademark Overview

On Tuesday, June 23, 2020, a trademark application was filed for TALLAC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TALLAC THERAPEUTICS trademark a serial number of 90016459. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by TALLAC THERAPEUTICS, INC.. The TALLAC THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-conjugates (TRAAC), namely, pharmaceuticals for the treatment and prevention of immune system related diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, and cancer
tallac therapeutics

General Information

Serial Number90016459
Word MarkTALLAC THERAPEUTICS
Filing DateTuesday, June 23, 2020
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7270000
Registration DateTuesday, January 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-conjugates (TRAAC), namely, pharmaceuticals for the treatment and prevention of immune system related diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, and cancer
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 21, 2020
Primary Code005
First Use Anywhere DateMonday, September 11, 2023
First Use In Commerce DateMonday, September 11, 2023

Trademark Owner History

Party NameTALLAC THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94158
Party NameTALLAC THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94158
Party NameTALLAC THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94158

Trademark Events

Event DateEvent Description
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, December 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 9, 2023USE AMENDMENT FILED
Tuesday, November 14, 2023SOU EXTENSION 5 GRANTED
Thursday, November 9, 2023SOU EXTENSION 5 FILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 18, 2023SOU EXTENSION 4 GRANTED
Sunday, June 18, 2023SOU EXTENSION 4 FILED
Sunday, June 18, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU EXTENSION 3 GRANTED
Tuesday, December 20, 2022SOU EXTENSION 3 FILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 21, 2022ASSIGNED TO EXAMINER
Tuesday, June 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 19, 2022SOU EXTENSION 2 GRANTED
Sunday, June 19, 2022SOU EXTENSION 2 FILED
Sunday, June 19, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 1, 2022CORRECTED NOA E-MAILED
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 28, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 1 FILED
Tuesday, December 28, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, December 8, 2021DIVISIONAL REQUEST RECEIVED
Monday, December 20, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 8, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 9, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2020NON-FINAL ACTION WRITTEN
Thursday, September 24, 2020ASSIGNED TO EXAMINER
Thursday, September 24, 2020ASSIGNED TO EXAMINER
Tuesday, July 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics tallac diseases disorders immune pharmaceuticals treatment prevention system cancer autoimmune inflammatory